Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$399M |
| 3 |
Abbott
ABT
|
+$381M |
| 4 |
Adobe
ADBE
|
+$353M |
| 5 |
Oracle
ORCL
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$407M |
| 2 |
Bank of America
BAC
|
+$368M |
| 3 |
TE Connectivity
TEL
|
+$366M |
| 4 |
Goldman Sachs
GS
|
+$302M |
| 5 |
Atlassian
TEAM
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.57% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.79% |
| 4 | Industrials | 9.79% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Thor Industries
THO
$4.08B
| $50.2M | 0.03% |
424,776
-83,175
| -16% | -$8.32M |
|
|
AZPN
377
DELISTED
Aspen Technology Inc
AZPN
| $49.9M | 0.03% |
226,570
-61
| -0% | -$11.7K |
|
378
Universal Display
OLED
$3.81B
| $49.9M | 0.03% |
260,533
+82,175
| +46% | +$13.6M |
|
379
Leslie's
LESL
$8.75M
| $49.5M | 0.03% |
358,170
+22,403
| +7% | +$2.46M |
|
|
EXE
380
Expand Energy Corp
EXE
$22.2B
| $49.5M | 0.03% |
643,181
-77,894
| -11% | -$6.4M |
|
|
UCB
381
United Community Banks
UCB
$4.28B
| $49.3M | 0.03% |
1,684,540
-121,207
| -7% | -$3.09M |
|
|
FISV
382
Fiserv Inc
FISV
$29.8B
| $48.9M | 0.03% |
368,156
-2,974
| -0.8% | -$365K |
|
383
Fulton Financial
FULT
$4.7B
| $48.4M | 0.03% |
2,940,469
+384,010
| +15% | +$5.39M |
|
384
Eastern Bankshares
EBC
$5.35B
| $48.2M | 0.03% |
3,394,466
+728,869
| +27% | +$9.1M |
|
385
OmniAb
OABI
$287M
| $48M | 0.03% |
7,777,897
+96,622
| +1% | +$475K |
|
386
Jefferies Financial Group
JEF
$12.8B
| $47.6M | 0.03% |
1,178,408
-56,123
| -5% | -$1.99M |
|
387
Simply Good Foods
SMPL
$924M
| $47.1M | 0.03% |
1,188,401
-358,216
| -23% | -$13.4M |
|
388
Toll Brothers
TOL
$14.4B
| $46.6M | 0.03% |
453,206
-63,889
| -12% | -$5.32M |
|
389
Sportradar
SRAD
$4.44B
| $46.2M | 0.03% |
4,180,442
+1,441,030
| +53% | +$14.2M |
|
390
BridgeBio Pharma
BBIO
$16.7B
| $46.2M | 0.03% |
1,143,563
-50
| -0% | -$1.5K |
|
391
Align Technology
ALGN
$13.1B
| $46.1M | 0.03% |
168,205
-9,297
| -5% | -$2.2M |
|
392
Valvoline
VVV
$5.12B
| $45.9M | 0.03% |
1,221,174
+3,628
| +0.3% | +$121K |
|
393
Coca-Cola Consolidated
COKE
$12.8B
| $45.6M | 0.03% |
490,820
-113,220
| -19% | -$8.2M |
|
394
Steven Madden
SHOO
$3.19B
| $45.3M | 0.03% |
1,078,162
-60,887
| -5% | -$2.21M |
|
395
Camden Property Trust
CPT
$11.5B
| $45.1M | 0.03% |
453,963
-381,460
| -46% | -$35.3M |
|
396
State Street
STT
$49.3B
| $45M | 0.03% |
580,988
-122,192
| -17% | -$8.52M |
|
397
Envista
NVST
$4.68B
| $45M | 0.03% |
1,868,446
-73,263
| -4% | -$1.75M |
|
398
Procore
PCOR
$7.61B
| $44.9M | 0.03% |
648,469
-2,192
| -0.3% | -$135K |
|
399
Gulfport Energy Corp
GPOR
$2.81B
| $44.8M | 0.03% |
336,157
-4,032
| -1% | -$519K |
|
400
Booz Allen Hamilton
BAH
$8.44B
| $44.7M | 0.03% |
349,465
+45,274
| +15% | +$5.64M |
|
Similar funds
Janus Henderson Group's Q4 2023 Portfolio in Review
As of Q4 2023, Janus Henderson Group held 2,657 positions worth $168B, up 9.8% from $153B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Janus Henderson Group's Q4 2023 filing shows 98 new, 642 increased, 1,760 reduced and 111 closed positions. Its largest new stake was Veralto: 2,881,576 shares worth $237M. The largest sale was Sherwin-Williams, an estimated $407M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2023 buy was Veralto: 2,881,576 shares worth $237M.
- Janus Henderson Group added most to Eli Lilly in Q4 2023, an estimated $534M increase.
- Janus Henderson Group's biggest Q4 2023 reduction was Sherwin-Williams, cutting an estimated $407M.
- Janus Henderson Group fully exited National Instruments Corp in Q4 2023, selling an estimated $243M.
- Janus Henderson Group's ten largest holdings make up 27% of its $168B portfolio in Q4 2023.
- Janus Henderson Group opened 98 new positions and closed 111 in Q4 2023.
- Janus Henderson Group's portfolio value rose 9.8% quarter-over-quarter to $168B.
Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.